Suppression of Murine Type-C RNA Virogenes by Type-specific Oncornavirus Vaccines: Prospects for Prevention of Cancer
Overview
Affiliations
Immunization of crossbred and F1 mice with combined killed and live Gross leukemia virus AKR type-C viral vaccines suppressed endogeneous N-type AKR virus up to 10,000-fold for significant periods during early life. Since several previous studies in the same and similar crossbred systems revealed direct correlations between low and high levels of type-C virus early in life with low and high incidences of leukemia and other cancers later in life, we believe that prospects for suppression of spontaneous neoplasms are good; however, 8-14 months will be required to achieve the final results. Should cancers be prevented by serotype-specific vaccines, such evidence would provide conclusive proof of endogenous viral etiology.
Rapp U J Virol. 1983; 45(2):755-65.
PMID: 6300432 PMC: 256470. DOI: 10.1128/JVI.45.2.755-765.1983.
Mayer A, Basombrio M, Pasqualini C Br J Cancer. 1980; 41(6):966-75.
PMID: 6252923 PMC: 2010361. DOI: 10.1038/bjc.1980.175.
Versteegen R, Oroszlan S J Virol. 1980; 33(3):983-92.
PMID: 6154154 PMC: 288632. DOI: 10.1128/JVI.33.3.983-992.1980.
Genovesi E, Marx P, Wheelock E J Exp Med. 1977; 146(2):520-34.
PMID: 327016 PMC: 2180763. DOI: 10.1084/jem.146.2.520.
Specificity of response to viral proteins in horses infected with equine infectious anemia virus.
Charman H, Long C, COGGINS L Infect Immun. 1979; 23(2):472-8.
PMID: 217831 PMC: 414189. DOI: 10.1128/iai.23.2.472-478.1979.